Filter by: Subject

Filter by: Subject

Results Per Page:

Drug susceptibility testing (DST) (3)
Clofazimine (2)
Clofazimine (CFZ) (2)
Drug-resistant tuberculosis (DR-TB) (2)
Linezolid (2)
Minimum inhibitory concentrations (MIC) (2)
960™ (1)
Abbott RealTime MTB (1)
Acquired immune deficiency syndrome (AIDS) (1)
Antibiotic-resistant (1)
Antimicrobial resistance (AMR) (1)
Antimycobacterials (1)
Antituberculosis therapy (1)
Assays (1)
AtpE mutations (1)
Bacteria (1)
Bias analysis (1)
Canonical variant (1)
Critical concentration (CC) (1)
Diagnostics (1)
Drug-resistant tuberculosis (1)
Drug-susceptibility testing (1)
Drugs (1)
Epidemics (1)
Extensively drug-resistant (XDR) (1)
Extensively drug-resistant tuberculosis (XDR-TB) (1)
External quality assessment (EQA) (1)
Fluoroquinolone (1)
Fluoroquinolones (FLQ) (1)
Genetic signatures (1)
GenoType MTBDRsl version 2.0 (1)
Genotypic analyses (1)
HIV/AIDS (1)
Human immunodeficiency virus (HIV) (1)
In vitro (1)
In vitro model (1)
In vitro mutants (1)
Infectious diseases (1)
KwaZulu-Natal (KZN) (1)
Line probe assay (LPA) (1)
MGIT™ (1)
Minimal inhibitory concentration (MIC) (1)
Minimum inhibitory concentration (1)
Missing data (1)
Molecular diagnostic testing (1)
Multicountry surveillance project (1)
Multidrug-resistant (MDR) (1)
Multidrug-resistant tuberculosis (MDR-TB) (1)
Mutants (1)
Mutation (1)
Network modeling (1)
Next generation sequencing (NGS) (1)
Noncanonical variant (1)
Performance (1)
Point mutation (1)
Population genetics (1)
PrimeMix (1)
PrimeStore(®) Molecular Transport Medium (PS-MTM) (1)
Pyrazinamide (1)
Pyrazinamide (PZA) (1)